Cardiology Headline News

Among patients with gout, those with cardiovascular monosodium urate deposits, confirmed via dual energy CT, demonstrate a higher risk for major adverse cardiac events, according to data published in Rheumatology.

A novel lead for use in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators exceeded the safety and efficacy thresholds in the LEADR trial, researchers reported at Heart Rhythm 2024.

Over the last 50 years, revascularization and pharmacotherapeutic innovations have led to significant reductions in major adverse CV events associated with both acute and chronic coronary diseases.

Dispensing of GLP-1 receptor agonists increased nearly 600% among adolescents and young adults in the United States from 2020 to 2023 and was particularly significant among girls and young women, a new study showed.

According to published results, perioperative IV dexamethasone was associated with decreased risk for pulmonary embolism and deep vein thrombosis after total joint arthroplasty for patients with a history of venous thromboembolism.

High ultra-processed food consumption in young children is associated with adiposity and other cardiometabolic risk factors, according to a study published in JAMA Network Open.

Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.

Pulsed field ablation lowered the odds of high residual atrial arrhythmia burden compared with thermal ablation for patients with atrial fibrillation at 1 year, according to a subanalysis of the ADVENT trial presented at Heart Rhythm 2024.

In two trials, OCT-guided PCI demonstrated superiority in imaging endpoints and improved procedural success compared with angiography and fluoroscopy alone, speakers reported.

A platform with a mapping system and a large-tip catheter with dual pulsed field and radiofrequency energies was noninferior to a conventional radiofrequency ablation system for treatment of persistent atrial fibrillation, data show.